Related Experiment Videos
Hepatocellular carcinoma in pregnancy. A case report
1Department of Obstetrics and Gynecology, University of Missouri-Columbia, USA. pgisi@kumc.edu
The Journal of Reproductive Medicine
|February 13, 1999
Summary
Hepatocellular carcinoma in pregnancy is rare but treatable with surgery. This case demonstrates successful surgical resection without terminating the pregnancy, offering new hope for expectant mothers.
Area of Science:
- Hepatology
- Oncology
- Maternal-Fetal Medicine
Background:
- Hepatocellular carcinoma (HCC) during pregnancy is exceptionally rare, with limited clinical experience and historical recommendations favoring pregnancy termination for treatment.
- Oral contraceptive use is identified as a potential risk factor in some cases of pregnancy-associated HCC.
Observation:
- A young, healthy woman diagnosed with HCC in her second trimester of pregnancy chose to continue the pregnancy.
- Treatment involved surgical resection via a right hepatectomy, preserving the pregnancy.
Findings:
- Successful surgical management of HCC in pregnancy is achievable without the need for adjuvant therapy.
- The patient and her child experienced a positive outcome, remaining healthy 24 months post-surgery.
Implications:
- Pregnancy termination is not a mandatory component of HCC treatment during gestation.
- Surgical resection represents a viable and effective therapeutic option for hepatocellular carcinoma in pregnant patients.
- This case expands treatment possibilities for rare cancers complicating pregnancy, prioritizing both maternal and fetal well-being.